期刊文献+

舒氨西林的临床评价 被引量:16

CLINICAL EVALUATION OF SULBACTAM/AMPICILLIN
暂未订购
导出
摘要 以国产舒氨西林治疗103例呼吸、尿路、胆道感染和腹腔炎,评价该药的疗效和安全性。总有效率为94.2%,细菌清除率93.2%。不良反应轻微,呈一过性,发生率为5.8%,主要有恶心、皮疹和SGPT轻度异常。同时进行了随机对照观察,56例呼吸和尿路感染患者接受舒氨西林,54例接受优立新,对照观察结果两组的有效率和不良反应发生率均相似。 A total of 103 patients,including respiratory, urinary,biliary tract infections and peritonitis, were treated with domestic made Sulbactam/Ampicillin. The efficacy and safety of the drug were evalua-ted,The effective rate xyas 94.2%the bacterial eradication rate was 93.2%。The adverse reaction was mild and transient, the incidence was 5.8%,mainly involved nausea,rash and slightly high SGPT. Arandomized comparative study was carried out simultaneously,56 Sases of respiratory and urinary tract infections treated with domestic sulbac-tam/Ampicillin were compared with 54 cases treated with Unasyn。The effective rate and adverse reaction of Sulbactam/Ampicllin was similiar to Unasyn.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 1994年第6期451-455,共5页 Chinese Journal of Antibiotics
关键词 舒巴坦 氨苄西林 舒氨西林 优立新 疗效 Sulbactam/Ampicillin Clinical evaluationl Randomized comparative study
  • 相关文献

同被引文献16

引证文献16

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部